Viewing Study NCT07066995

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:35 PM
Ignite Modification Date: 2026-01-02 @ 3:25 PM
Study NCT ID: NCT07066995
Status: RECRUITING
Last Update Posted: 2025-07-15
First Post: 2025-07-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer
Sponsor: Essen Biotech
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
None Pancreatic Carcinoma View
None Pancreatic Cancer Non-resectable View
None Pancreatic Cancer Stage IV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None claudin 18.2 View
None Pancreatic Cancer View
None Pancreatic Carcinoma View
None CAR-T View
None Mesothelin View